Pharmdaily
Allergy Blood Pressure Diabetes Fitness Seniors Sex Sleep Stomach Email this site to a friend
    Home    Public Health    Health Highlights: May 11, 2009
Free Samples
Choose a Topic
     Allergy / Respiratory
     Alternative Medicine
     Arthritis, Bones & Joints
     Blood Pressure
     Cancer
     Care Giving
     Circulatory System
     Clinical Trials
     Cosmetic
     Dental / Oral
     Diabetes
     Disabilities
     Environmental Health
     Eye Care / Vision
     Fitness & Exercise
     Gastrointestinal Problems
     General Health
     Head & Neck
     Health & Technology
     Hearing
     Heart / Cardiovascular
     Infectious Disease
     Kids' Health
     Men's Health
     Mental Health
     Neurological
     Nutrition / Vitamins
     Pregnancy
     Public Health
     Seniors
     Sexual Health
     Sleep Disorders
     Women's Health
Health Highlights: May 11, 2009


Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

FDA Investigating 2 Delaware Deaths That May Be Linked to Heparin

The U.S. Food and Drug Administration has sent a team to investigate the deaths of two Delaware patients who died over the weekend after taking the blood thinner heparin, the Wall Street Journal reported.

The deaths were confirmed by a spokesman from Beebe Medical Center in Lewes, Del., after three people suffered medical problems after using heparin. All three people were using the drug supplied by Baxter International Inc., of Deerfield, Ill., although the spokesman said there is no evidence that directly ties heparin to the deaths, the Journal reported. Baxter spokeswoman Erin Gardiner told the newspaper that the company immediately contacted the FDA, and both the agency and Baxter sent medical teams to Delaware to investigate.

The people who died, identified only as a 71-year-old man and a 64-year-old woman, were flown by helicopter from Beebe. One died at Christiana Hospital in Delaware, and the other died at the University of Maryland Medical Center. Gardiner said both received pre-mixed intravenous bags of heparin.

In 2008, tainted heparin bulk supplies, vials of the medicine and drug-coated medical devices reportedly were tied to some 80 deaths and led to a recall of heparin from several companies. The current investigation is so far focused on North American sources and not product from China, according to the Journal. Last year's cases mostly involved allergic reactions and cardiac complications, while the Delaware deaths involved cranial bleeding, Gardiner told the newspaper.

-----

Obama Praises Health Industry's Offer of Savings

Calling it a "watershed event," President Barack Obama on Monday applauded an offer by health care industry leaders to voluntarily slow rate increases. The move is designed to help provide heath insurance for the estimated 50 million Americans who have none and who are a focal point of the administration's health care reform proposals, the Associated Press reported.

      NEXT PAGE  
Print This Article  PRINT Email this article  EMAIL RSS Feed Information  RSS Comment on this Article
CURRENT RATING: 0 out of 50 out of 50 out of 50 out of 50 out of 5 (0 VOTE)
BOOKMARKS: delicious hugg digg reddit technorati newsvine stumbleupon google
Register Now for Free Health Tips!
Video Of The Day
Hearing Babies Learn How to Communicate with Signs
Learning sign language can help hearing children communicate before they can speak. Research indicates learning sign language...
Hearing Babies Learn How to Communicate with Signs
Most Viewed Public Health Articles
Seniors Often Misstate Stroke History
CDC Shifts Swine Flu Focus to Likely Impact in the Fall
Swine Flu: A Primer
Featured Videos
ADHD in School: How to Stay in the Loop
Separating Depression From Being Blue
Understanding Lung Cancer
What Are the Symptoms of Ovarian Cancer?
View All Videos
People who read this article also viewed
Germicide Might Guard Against HIV Infection
Obama Lifts Ban on Stem Cell Research
Seniors Often Misstate Stroke History
Mediterranean Diet Aids the Aging Brain: Study
Inflammation May Play Role in Sleep Duration
Subscribe to PharmDaily.com updates: RSS Feed Information Add to My Yahoo! Add to Google My AOL My MSN
Pharmdaily.com is a property of DedicatedMedia.com
Other DedicatedMedia.com Properties: Cardevotion.com | ClassesOnlineUSA.com | Just4Classes.com | CPADNA | Prospect-Digital
Email this site to a friend